Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07589621 · ClinicalTrials.gov registry record · NA
Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns
A NA study, sponsored by Florida State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT07589621: Recruiting NA study, sponsored by Florida State University.
NCT07589621 is a NA study that is actively recruiting participants, run by Florida State University. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07589621, a NA study, is actively recruiting participants, sponsored by Florida State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a progressive muscle relaxation intervention for appearance concerns.
Primary Outcome
Self-report scale that measures appearance anxiety symptoms. Scores range from 16 to 80 with higher scores indicating higher levels of appearance concerns.
Interventions
- BEHAVIORAL Progressive Muscle Relaxation
- BEHAVIORAL Safety Behavior Fading for Appearance Concerns
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-05-29 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07589621 shows while recruiting
NCT07589621 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Progressive Muscle Relaxation is the first listed.
NCT07589621 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07589621 about?
NCT07589621 is a clinical study titled "Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns". The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a progressive muscle relaxation intervention for appearance concerns.
What is the current status of trial NCT07589621?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-05-29. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07589621?
The interventions under investigation include: Progressive Muscle Relaxation (BEHAVIORAL), Safety Behavior Fading for Appearance Concerns (BEHAVIORAL).
Who is sponsoring clinical trial NCT07589621?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07589621's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI